This company seems to have been delisted
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Albireo Pharma
ALBO
S$56.78
Share price
0.00%
Change (1 day)
109.61%
Change (1 year)
Categories
Market capitalization of Albireo Pharma (ALBO)
Last known market cap: S$1.17 Billion
On May 5, 2023 Albireo Pharma had a market cap of S$1.17 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Albireo Pharma from 2007 to 2023
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2023 | S$1.20 B | 101.69% |
| 2022 | S$0.59 B | -1.29% |
| 2021 | S$0.60 B | -35.92% |
| 2020 | S$0.94 B | 117% |
| 2019 | S$0.43 B | 8.92% |
| 2018 | S$0.40 B | 31.64% |
| 2017 | S$0.30 B | 88.71% |
| 2016 | S$0.16 B | 419.42% |
| 2015 | S$31.08 M | -24.57% |
| 2014 | S$41.21 M | -32.29% |
| 2013 | S$60.86 M | 49.39% |
| 2012 | S$40.74 M | 33.23% |
| 2011 | S$30.57 M | -50.92% |
| 2010 | S$62.31 M | -57.18% |
| 2009 | S$0.14 B | -10.97% |
| 2008 | S$0.16 B | -75.89% |
| 2007 | S$0.67 B |
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | S$1.25 B | 6.44% | 🇺🇸 USA |